Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
234.20   -3.62 (1.52%)  232.00 - 239.99  158,200

Overview

 
Avg Volume (4 weeks):217,557
4 Weeks Range:222.35 - 292.29
4 Weeks Price Volatility (%):
16.94%
52 Weeks Range:15.53 - 325.98
52 Weeks Price Volatility (%):
70.44%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

4457  3108  909  176 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HMNY 0.03+0.001 
 AMD 19.98+0.21 
 GDX 18.79+0.07 
 EEM 42.40+0.19 
 WPZ 47.37-0.18 
 BAC 30.87+0.13 
 SPY 285.67+0.61 
 ABEV 4.86-0.05 
 GE 12.300.00 
 MU 48.07+0.96 
Partners & Brokers